Menu
1 min read · estimated
APPROVED USE
What FDA approved
With carboplatin and paclitaxel as first-line therapy for adults with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal.
LAMPGEN ANALYSIS
Why it matters
POD1UM-303 established a first-line combination of a PD-1 inhibitor and platinum-taxane chemotherapy in this rare cancer.
What research teams should watch
Track induction cycles and the transition from combination therapy to continued retifanlimab in the visit calendar.
PRIMARY RECORDS